• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Wallop of Symptoms and Co-morbidities on COVID-19 Outcome.症状和合并症对新冠病毒疾病结局的冲击
Open Respir Med J. 2021 Nov 10;15:46-51. doi: 10.2174/1874306402115010046. eCollection 2021.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
3
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.斋浦尔市522例COVID-19住院患者的羟氯喹特性、治疗结果及作用:一项流行病学临床研究
J Assoc Physicians India. 2020 Jun;68(6):13-19.
4
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.COVID-19 门诊患者的早期抗病毒治疗(FLARE):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 8;22(1):193. doi: 10.1186/s13063-021-05139-2.
5
Clinico-Epidemiological Profiles of COVID-19 Elderly Patients in Guwahati City, Assam, India: A Cross-Sectional Study.印度阿萨姆邦古瓦哈蒂市新冠肺炎老年患者的临床流行病学概况:一项横断面研究
Cureus. 2022 Apr 11;14(4):e24043. doi: 10.7759/cureus.24043. eCollection 2022 Apr.
6
Pre-morbidity and COVID-19 disease outcomes in Pakistani population: A cross-sectional study.巴基斯坦人群中的病前状况与新冠病毒病结局:一项横断面研究。
Pak J Med Sci. 2022 Jan-Feb;38(1):287-292. doi: 10.12669/pjms.38.1.4235.
7
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.慢性丙型肝炎合并和不合并肝硬化以及 COVID-19 感染患者的生存和结局:一项多中心回顾性研究。
World J Gastroenterol. 2021 Nov 14;27(42):7362-7375. doi: 10.3748/wjg.v27.i42.7362.
8
Prevalence of co-morbidities and its association with mortality in Indian patients with COVID-19: A meta-analysis.印度新冠肺炎患者的合并症患病率及其与死亡率的关联:一项荟萃分析。
Indian J Anaesth. 2022 Jun;66(6):399-418. doi: 10.4103/ija.ija_845_21. Epub 2022 Jun 21.
9
Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.伊朗马什哈德医科大学的一项横断面研究:严重 COVID-19 感染的人口统计学和临床特征。
BMC Infect Dis. 2021 Jul 7;21(1):656. doi: 10.1186/s12879-021-06363-6.
10
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.

本文引用的文献

1
Medical management of COVID-19 clinic.新型冠状病毒肺炎诊所的医疗管理
J Biomed Res. 2020 Sep 30;34(6):416-421. doi: 10.7555/JBR.34.20200118.
2
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.吸入性类固醇 Ciclesonide 通过靶向细胞培养中的病毒复制转录复合物来阻断 SARS-CoV-2 RNA 复制。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01648-20.
3
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis.吸烟对新冠病毒疾病症状严重程度的影响:系统评价与荟萃分析
Pulm Med. 2020 Sep 8;2020:7590207. doi: 10.1155/2020/7590207. eCollection 2020.
4
Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak.新型冠状病毒病在西班牙爆发期间的慢性肾脏病和急性肾损伤。
Nephrol Dial Transplant. 2020 Aug 1;35(8):1353-1361. doi: 10.1093/ndt/gfaa189.
5
Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis.基础呼吸系统疾病,特别是 COPD 和吸烟,与严重的 COVID-19 结局相关:系统评价和荟萃分析。
Respir Med. 2020 Sep;171:106096. doi: 10.1016/j.rmed.2020.106096. Epub 2020 Jul 30.
6
The effect of smoking on COVID-19 severity: A systematic review and meta-analysis.吸烟对 COVID-19 严重程度的影响:系统评价和荟萃分析。
J Med Virol. 2021 Feb;93(2):1045-1056. doi: 10.1002/jmv.26389. Epub 2020 Aug 13.
7
Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.HNC-LL 评分预测 2019 年冠状病毒病严重程度的开发和验证。
EBioMedicine. 2020 Jul;57:102880. doi: 10.1016/j.ebiom.2020.102880. Epub 2020 Jul 7.
8
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.患有糖尿病和 COVID-19 患者的临床特征和转归与降糖药物的关系。
Diabetes Care. 2020 Jul;43(7):1399-1407. doi: 10.2337/dc20-0660. Epub 2020 May 14.
9
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.美国住院新冠病毒疾病(COVID-19)患者的血糖特征及临床结局
J Diabetes Sci Technol. 2020 Jul;14(4):813-821. doi: 10.1177/1932296820924469. Epub 2020 May 9.
10
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.

症状和合并症对新冠病毒疾病结局的冲击

Wallop of Symptoms and Co-morbidities on COVID-19 Outcome.

作者信息

Abo ElNaga Heba H, AbdelHalim Hesham A, Abdellatif Mohamed, Bg Haroun, Elnagdy Basem, Ashraf Taghreed, ElNaggar Bahaa, S Eldin Passant, Ta Ismail, Mosaad Beshoy, Ismail Tasbeeha, Boules Rasmy, Methuselah Shawky, Rafaat Paula

机构信息

Pulmonary Medicine Department, Faculty of Medicine, October 6 University, Giza, Egypt.

Pulmonary Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Open Respir Med J. 2021 Nov 10;15:46-51. doi: 10.2174/1874306402115010046. eCollection 2021.

DOI:10.2174/1874306402115010046
PMID:35136454
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8719279/
Abstract

BACKGROUND

Fever, cough, fatigue, and myalgia are usually the original clinical picture of the COVID-19 pandemic, which appears non-specific and not exclusive.

OBJECTIVES

To illustrate the clinical picture pattern and assess the prevalence of underlying co-morbidities and their correlation with the severity of COVID-19 infected patients.

METHODS

A cross-sectional online survey included 580 participants who were either suspected or confirmed with COVID-19 infection.

RESULTS

The severity of the disease significantly correlates with both age (p=.01) and the time lag of the diagnosis of COVID-19 (p=.03). Hypertension (p=.015) and diabetes mellitus (p<.01) were significantly associated with the duration of symptoms. A wide range of ages (21-60 years) seemed to be the only risk factor for the severity. When symptoms were tested, dyspnea appeared to be the most prevalent symptom, predicting a more severe disease (OR= .066, 95% CI: .022- .200), followed by diarrhea (OR= .285, 95% CI: .122-.663), then fever (OR= .339, 95% CI: .139-.824). During the examination of co-morbidities influences on the severity, the only major co-morbidity that predicted a more severe disease was IHD (OR= .218, 95% CI: .073- .648), p= .006.

CONCLUSION

Special consideration is required for patients with COVID-19 with an associated longer gap between symptoms and diagnosis and associated co-morbidities including hypertension, diabetes, and established chronic kidney disease (CKD), for which this study proved its profound influence on the severity of the illness and duration of symptoms.

摘要

背景

发热、咳嗽、乏力和肌痛通常是新冠疫情最初的临床表现,这些表现并无特异性且并非新冠所特有。

目的

阐述临床表现模式,并评估新冠感染患者潜在合并症的患病率及其与疾病严重程度的相关性。

方法

一项横断面在线调查纳入了580名疑似或确诊新冠感染的参与者。

结果

疾病严重程度与年龄(p = 0.01)和新冠确诊时间间隔(p = 0.03)均显著相关。高血压(p = 0.015)和糖尿病(p < 0.01)与症状持续时间显著相关。广泛的年龄范围(21至60岁)似乎是疾病严重程度的唯一风险因素。对症状进行检测时,呼吸困难似乎是最常见的症状,预示疾病更严重(OR = 0.066,95% CI:0.022 - 0.200),其次是腹泻(OR = 0.285,95% CI:0.122 - 0.663),然后是发热(OR = 0.339,95% CI:0.139 - 0.824)。在检查合并症对疾病严重程度的影响时,唯一能预测疾病更严重的主要合并症是缺血性心脏病(OR = 0.218,95% CI:0.073 - 0.648),p = 0.006。

结论

对于新冠患者,若症状与诊断之间的间隔时间较长且存在包括高血压、糖尿病和已确诊的慢性肾脏病(CKD)在内的合并症,需要给予特别关注,本研究证明这些合并症对疾病严重程度和症状持续时间有深远影响。